December 4, 2020

Talabostat mesylate

Talabostat mesylate 

To Order Contact us: bjorn@lembcke.dk

Talabostat mesylate

B3941-5.1 10 mM (in 1mL DMSO)
EUR 277
Description: IC50: 1 nMTalabostat mesilate (PT-100; Val-boroPro) is an orally active, specific inhibitor of dipeptidyl peptidases for DPP4, including tumor-associated fibroblast activation protein- (FAP).

Talabostat mesylate

B3941-50 50 mg
EUR 920
Description: IC50: 1 nMTalabostat mesilate (PT-100; Val-boroPro) is an orally active, specific inhibitor of dipeptidyl peptidases for DPP4, including tumor-associated fibroblast activation protein- (FAP).

Talabostat (mesylate)

HY-13233A 50mg
EUR 612

Talabostat isomer mesylate

HY-13233B 10mg
EUR 555

Talabostat

HY-13233 50mg
EUR 612

Bromocryptine (mesylate)

2916-250
EUR 327

Bromocryptine (mesylate)

2916-50
EUR 131

Rasagiline mesylate

2237-250
EUR 251

Rasagiline mesylate

2237-50
EUR 109

Nafamostat Mesylate

1760-10
EUR 137

Nafamostat Mesylate

1760-50
EUR 354

Deferoxamine Mesylate

1883-1000
EUR 251

Deferoxamine Mesylate

1883-500
EUR 185

Benztropine mesylate

B1554-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Benztropine is a dopamine transporter (DAT) inhibitor with IC50 of 118 nM.

Benztropine mesylate

B1554-50 50 mg
EUR 128
Description: Benztropine is a dopamine transporter (DAT) inhibitor with IC50 of 118 nM.

Benztropine mesylate

B1554-S Evaluation Sample
EUR 81
Description: Benztropine is a dopamine transporter (DAT) inhibitor with IC50 of 118 nM.

Trovafloxacin mesylate

B1565-25
EUR 784

Trovafloxacin mesylate

B1565-5
EUR 240

Apatinib mesylate

B1608-25
EUR 648

Apatinib mesylate

B1608-5
EUR 207

Danofloxacin Mesylate

B1720-100 100 mg
EUR 134
Description: Danofloxacin is a fluoroquinolone antibacterial for veterinary use, with MIC90 of 0.28 ?M.

Danofloxacin Mesylate

B1720-1000 1 g
EUR 586
Description: Danofloxacin is a fluoroquinolone antibacterial for veterinary use, with MIC90 of 0.28 ?M.

Danofloxacin Mesylate

B1720-250 250 mg
EUR 244
Description: Danofloxacin is a fluoroquinolone antibacterial for veterinary use, with MIC90 of 0.28 ?M.

Eprosartan Mesylate

B1746-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Eprosartan is a nonpeptide angiotensin II receptor antagonist with IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively.

Eprosartan Mesylate

B1746-50 50 mg
EUR 128
Description: Eprosartan is a nonpeptide angiotensin II receptor antagonist with IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively.

Saquinavir mesylate

B1999-10
EUR 142

Pefloxacin Mesylate

B2003-100 100 mg
EUR 96
Description: Pefloxacin mesylate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse)

Pefloxacin Mesylate

B2003-10000 10 g
EUR 108
Description: Pefloxacin mesylate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse)

Pefloxacin Mesylate

B2003-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Pefloxacin mesylate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse)

Pefloxacin Mesylate

B2003-50000 50 g
EUR 224
Description: Pefloxacin mesylate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse)

Prexasertib mesylate

B2067-25
EUR 675

Prexasertib mesylate

B2067-5
EUR 207

Reboxetine mesylate

B2124-10 10 mg
EUR 139
Description: Reboxetine is a norepinephrine reuptake inhibitor with Ki of 8.2 nM.

Reboxetine mesylate

B2124-50 50 mg
EUR 431
Description: Reboxetine is a norepinephrine reuptake inhibitor with Ki of 8.2 nM.

Reboxetine mesylate

B2124-S Evaluation Sample
EUR 81
Description: Reboxetine is a norepinephrine reuptake inhibitor with Ki of 8.2 nM.

Pritelivir mesylate

B2154-25
EUR 457

Pritelivir mesylate

B2154-5
EUR 153

Ibutamoren mesylate

B2400-25
EUR 349

Ibutamoren mesylate

B2400-5
EUR 131

Eribulin mesylate

B3386-.5 500 ?g
EUR 1331
Description: Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules.

Eribulin mesylate

B3386-1 1 mg
EUR 1558
Description: Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules.

Dihydroergotamine mesylate

B3459-100 100 mg
EUR 171

Dihydroergotamine mesylate

B3459-250 250 mg
EUR 332

Dihydroergotamine mesylate

B3459-50 50 mg
EUR 122

Naltriben mesylate

B5030-10 10 mg
EUR 308

Naltriben mesylate

B5030-50 50 mg
EUR 1136

Clocinnamox mesylate

B5031-2 2 mg
EUR 308

Delavirdine mesylate

B1050-10 10 mg
EUR 139
Description: Delavirdine(U 90152) mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine mesylate

B1050-100 100 mg
EUR 195
Description: Delavirdine(U 90152) mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine mesylate

B1050-200 200 mg
EUR 303
Description: Delavirdine(U 90152) mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine mesylate

B1050-5.1 10 mM (in 1mL DMSO)
EUR 150
Description: Delavirdine(U 90152) mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine mesylate

B1050-50 50 mg
EUR 176
Description: Delavirdine(U 90152) mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Apilimod mesylate

B1129-25
EUR 544

Apilimod mesylate

B1129-5
EUR 175

Gatifloxacin mesylate

B1216-1000 1 g
EUR 139
Description: Gatifloxacin (mesylate) is an antibiotic of the fourth-generation fluoroquinolone family, it inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

Gatifloxacin mesylate

B1216-5000 5 g
EUR 300
Description: Gatifloxacin (mesylate) is an antibiotic of the fourth-generation fluoroquinolone family, it inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

Tigecycline mesylate

B1220-10 10 mg
EUR 212
Description: Tigecycline mesylate a first-in-class, broad spectrum antibiotic with activity against antibiotic-resistant organisms.

Tigecycline mesylate

B1220-100 100 mg
EUR 592
Description: Tigecycline mesylate a first-in-class, broad spectrum antibiotic with activity against antibiotic-resistant organisms.

Tigecycline mesylate

B1220-200 200 mg
EUR 809
Description: Tigecycline mesylate a first-in-class, broad spectrum antibiotic with activity against antibiotic-resistant organisms.

Tigecycline mesylate

B1220-50 50 mg
EUR 340
Description: Tigecycline mesylate a first-in-class, broad spectrum antibiotic with activity against antibiotic-resistant organisms.

Tigecycline mesylate

B1220-500 500 mg
EUR 991
Description: Tigecycline mesylate a first-in-class, broad spectrum antibiotic with activity against antibiotic-resistant organisms.

Phentolamine Mesylate

B1363-100 100 mg
EUR 147
Description: Phentolamine Mesylate is a alpha 1- and alpha 2-blocking agent. Phentolamine leads to an increase in FBM by preferentially antagonizing presynaptic alpha 2-adrenoreceptors over postsynaptic alpha 1-adrenoreceptors. This influence of phentolamine on FBM ma

Phentolamine Mesylate

B1363-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Phentolamine Mesylate is a alpha 1- and alpha 2-blocking agent. Phentolamine leads to an increase in FBM by preferentially antagonizing presynaptic alpha 2-adrenoreceptors over postsynaptic alpha 1-adrenoreceptors. This influence of phentolamine on FBM ma

Phentolamine Mesylate

B1363-50 50 mg
EUR 128
Description: Phentolamine Mesylate is a alpha 1- and alpha 2-blocking agent. Phentolamine leads to an increase in FBM by preferentially antagonizing presynaptic alpha 2-adrenoreceptors over postsynaptic alpha 1-adrenoreceptors. This influence of phentolamine on FBM ma

Phentolamine Mesylate

B1363-S Evaluation Sample
EUR 81
Description: Phentolamine Mesylate is a alpha 1- and alpha 2-blocking agent. Phentolamine leads to an increase in FBM by preferentially antagonizing presynaptic alpha 2-adrenoreceptors over postsynaptic alpha 1-adrenoreceptors. This influence of phentolamine on FBM ma

Pergolide mesylate

B1485-2.5 2.5 mg
EUR 168
Description: Pergolide mesylate is an antiparkinsonian agent which functions as a dopaminergic agonist.

Pergolide mesylate

B1485-5.1 10 mM (in 1mL DMSO)
EUR 302
Description: Pergolide mesylate is an antiparkinsonian agent which functions as a dopaminergic agonist.

Pergolide mesylate

B1485-S Evaluation Sample
EUR 81
Description: Pergolide mesylate is an antiparkinsonian agent which functions as a dopaminergic agonist.

Deferoxamine mesylate

B6068-100 100 mg
EUR 108
Description: Deferoxamine mesylate is a specific iron-chelating agent [1][2][3]Deferoxamine mesylate can be used for treating acute iron intoxication. Deferoxamine complexed with iron to form ferrioxamine and then prevented the iron from entering into further chemical reactions.

Deferoxamine mesylate

B6068-500 500 mg
EUR 142
Description: Deferoxamine mesylate is a specific iron-chelating agent [1][2][3]Deferoxamine mesylate can be used for treating acute iron intoxication. Deferoxamine complexed with iron to form ferrioxamine and then prevented the iron from entering into further chemical reactions.

Sildenafil mesylate

B6073-25 25 mg
EUR 108
Description: IC50: 3.5 nMSildenafil mesylate is an inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).PDE5 is the predominant phosphodiesterase in the corpus cavernosum.

Sildenafil mesylate

B6073-50 50 mg
EUR 142
Description: IC50: 3.5 nMSildenafil mesylate is an inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).PDE5 is the predominant phosphodiesterase in the corpus cavernosum.

Sildenafil mesylate

B6073-500 500 mg
EUR 595
Description: IC50: 3.5 nMSildenafil mesylate is an inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).PDE5 is the predominant phosphodiesterase in the corpus cavernosum.

Bromocriptine mesylate

B6298-5.1 10 mM (in 1mL DMSO)
EUR 108

Bromocriptine mesylate

B6298-50 50 mg
EUR 197

Dihydroergocristine mesylate

B6313-100 100 mg
EUR 226

Dihydroergotoxine mesylate

B6327-100 100 mg
EUR 179

Dihydroergotoxine mesylate

B6327-50 50 mg
EUR 122

Tetrindole mesylate

B6419-10 10 mg
EUR 268

Tetrindole mesylate

B6419-50 50 mg
EUR 973

Pirlindole mesylate

B6420-10 10 mg
EUR 200

Pirlindole mesylate

B6420-25 25 mg
EUR 408

Pirlindole mesylate

B6420-5 5 mg
EUR 129

Pirlindole mesylate

B6420-50 50 mg
EUR 725

Dalfopristin Mesylate

D034-1MG 1 mg
EUR 318

Dalfopristin Mesylate

D034-5MG 5 mg
EUR 1040

Danofloxacin Mesylate

D090-100MG 100mg
EUR 74

Danofloxacin Mesylate

D090-1G 1g
EUR 247

Traxoprodil Mesylate

20-abx184454
  • EUR 1191.00
  • EUR 1511.00
  • 100 mg
  • 1 g
  • Shipped within 1-2 weeks.

Imatinib mesylate

20-abx076675
  • EUR 384.00
  • EUR 244.00
  • 100 mg
  • 20 mg
  • Shipped within 5-12 working days.

Imatinib Mesylate

E1KS1026 250mg
EUR 247

Nafamostat mesylate

E1KS1386 10mg
EUR 247

Quinupristin (mesylate)

C5450-1 1 mg
EUR 326
Description: Quinupristin is a streptogramin antibiotic. Streptogramins, a class of antibiotics, are effective in the treatment of vancomycin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, which are two of the most rapidly growing strains of multidrug-resistant bacteria.

Quinupristin (mesylate)

C5450-5 5 mg
EUR 950
Description: Quinupristin is a streptogramin antibiotic. Streptogramins, a class of antibiotics, are effective in the treatment of vancomycin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, which are two of the most rapidly growing strains of multidrug-resistant bacteria.

Dalfopristin (mesylate)

C5482-1 1 mg
EUR 432
Description: Dalfopristin (mesylate) is a streptogramin antibiotic and a 50S ribosome inhibitor [1][2]. Streptogramins are produced by a variety of Streptomyces sp as a mixture (ratio of 7:3) of two chemically unrelated compounds, type A and B.

Dalfopristin (mesylate)

C5482-5 5 mg
EUR 1301
Description: Dalfopristin (mesylate) is a streptogramin antibiotic and a 50S ribosome inhibitor [1][2]. Streptogramins are produced by a variety of Streptomyces sp as a mixture (ratio of 7:3) of two chemically unrelated compounds, type A and B.

Ralfinamide mesylate

B7569-10 10 mg
EUR 324

Ralfinamide mesylate

B7569-50 50 mg
EUR 1211

Talabostat mesylate